FeesSafety
Pluang+

Engineer Gold Mines completes 2026 drill core sampling at TAG Property in BC, advancing gold exploration.

Market News
03 Nov 2026, 14:25 WIB
TheNewswire
View Source
Bullish
Engineer Gold Mines completes 2026 drill core sampling at TAG Property in BC, advancing gold exploration.

Engineer Gold Mines Ltd. has finished its 2026 infill diamond drill core sampling program at the TAG Property, part of its Engineer Gold Project in British Columbia. The company collected 538 samples from 20 holes totaling 685 meters, now sent for gold and multi-element analysis. Results will guide further sampling in 2027 and help define drill targets for a future resource estimate. The TAG Property is a key part of the project, linked to a 6 km gold-silver structure, with historical drilling showing promising gold and silver grades, supporting ongoing exploration efforts.

Engineer Gold Mines' 2026 drill core sampling at TAG is the subject, with Pluang's Basic Materials sector data providing market context. As of Nov 03, 2026 19:12 WIB, out of 83 priced US stocks, 20 rose and 59 fell. Among notable movers, HYMC traded at USD 15.92 with a 2.51% decline and an 11-day typical hold time, EXK at USD 7.05 down 2.49% but with a buy-heavy order activity of 62%, and HBM at USD 21.17 down 2.44% with a 25-day hold time.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
20 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App